MLV Capital reaffirmed their buy rating on shares of MannKind Corp. (NASDAQ:MNKD) in a report issued on Thursday, Analyst Ratings Network.com reports. They currently have a $9.00 target price on the stock, down from their previous target price of $10.00. MannKind Corporation (NASDAQ:MNKD) stock advanced 6.31% and finished the last session at $6.40. The EPS of the stock remained -0.59. Company’s market capitalization is $2.36 billion.
Synta Pharmaceuticals Corp. (NASDAQ:SNTA) reported on progress with lead compounds from its Hsp90-Inhibitor Drug Conjugate (:HDC) platform at the IASLC 14th Annual Targeted Therapies of the Treatment of Lung Cancer Meeting in Santa Monica, California. The new compounds, consisting of an Hsp90-inhibitor conjugated with SN-38 (HDC SN-38) and an Hsp90-inhibitor conjugated with docetaxel (HDC docetaxel), demonstrated proof of principle in multiple preclinical cancer models. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) stock opened at $6.85 in last trading session, and closed at $7.01, trading in the range of $6.63 – $7.20. The stock showed a positive/negative weekly performance of 8.77%.
Celladon Corp (NASDAQ:CLDN) announced that Celladon and Servier have entered into an option agreement for a potential worldwide ex-U.S. research collaboration and license agreement for the discovery and development of novel SERCA2b modulators for the treatment of type 2 diabetes and other metabolic diseases. The collaboration would leverage Celladon’s novel compounds, proprietary assays, and screening technology for isolation of small molecule modulators of SERCA enzymes. Celladon Corp (NASDAQ:CLDN) shares closed at $9.50 on last trade day, by losing – 25.50%. Stock 52 week range is $7.45 – $14.68. Company’s market capitalization is $167.91 million.
TheStreet Quant Ratings rates Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) as a sell. The company’s weaknesses can be seen in multiple areas, such as its unimpressive growth in net income and weak operating cash flow Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) stock opened at $13.95 in last trading session and closed at $14.64. The 52 week range of the stock is $3.57 – $15.65 and the day range was $13.95 – $14.69.